This Cochrane Group is no longer active

Due to changes in NIHR funding in evidence synthesis, this Cochrane Group is no longer active. We are so grateful for the work of our contributors.

If you would like to get involved with Cochrane, please visit our Join Cochrane pages.

To learn more about Cochrane, visit our homepage.

If you would like to propose a topic for a Cochrane Review, please see our instructions for authors.

If you have any queries, please contact Cochrane Support.

Origins and funding

Following an exploratory meeting on the 31st May 1994 and registration with the Cochrane Collaboration on the 5th October 1994 - the Cochrane Review Group on Peripheral Vascular Diseases (PVD) was formed in October 1995. In June 2015 the Group was renamed Cochrane Vascular.

Cochrane Vascular has been supported by funding from the Chief Scientist Office of the Scottish Executive (formerly the Scottish Office) since 1 January 1995. 

Cochrane Vascular has also secured funding from the National Institute of Health Research (NIHR), in collaboration with Newcastle-upon-Tyne Hospitals NHS Foundation Trust. 

Cochrane's central functions are funded by royalties from its publishers, John Wiley & Sons Limited, which come from sales of subscriptions to the Cochrane Library.

The individual entities of Cochrane are funded by a large variety of governmental, institutional and private funding sources, and are bound by organisation-wide policy limiting uses of funds from corporate sponsors. Please visit our funders page for a list of all Cochrane funders.